IP Library Granted Patent US 9,259,423
Granted Patent B2
US 9,259,423 · App. 13/555,044 · Granted Feb 16, 2016

Method of treatment for mental disorders

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,259,423
App. No.
13/555,044
Granted
Feb 16, 2016
Kind
B2
Abstract

The invention relates to a medicament or a method for treating mental disorders, in detail, ADHD comprising lurasidone, or a combination of lurasidone and a D 4 receptor agonist.

Claims (3)

1. A method for improving attention function in schizophrenia and/or bipolar disorder which comprises administering a therapeutically effective amount of lurasidone or a pharmaceutically acceptable acid addition salt thereof as the sole active ingredient to a mammal in need thereof.

2. The method of claim 1 wherein the attention function is attention function in bipolar disorder.

3. The method of claim 1 wherein improving attention function is one or more selected from the group consisting of improving continuous concentration, improving rapid-reaction and improving visual/perceptual seeking.

Assignments (2)
CHANGE OF NAME Recorded Nov 21, 2022
From: SUMITOMO DAINIPPON PHARMA CO., LTD.
To: SUMITOMO PHARMA CO., LTD.
Reel/Frame 061972/0730 →
CHANGE OF NAME Recorded Oct 7, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 033905/0778 →